SURAKSHA DIAGNOSTIC
Back to Cashflow Statement
|
SURAKSHA DIAGNOSTIC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-25 Cr | ₹-24 Cr | ₹1.09 Cr | ₹3.21 Cr | ₹-10 Cr |
What is the latest Cash Flow from Financing Activities ratio of SURAKSHA DIAGNOSTIC ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-25 Cr |
Mar2023 | ₹-24 Cr |
Mar2022 | ₹1.09 Cr |
Mar2021 | ₹3.21 Cr |
Mar2020 | ₹-10 Cr |
How is Cash Flow from Financing Activities of SURAKSHA DIAGNOSTIC Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-25 Cr | Negative | |
Mar2023 | ₹-24 Cr | Negative | |
Mar2022 | ₹1.09 Cr | -66.15 | |
Mar2021 | ₹3.21 Cr | Positive | |
Mar2020 | ₹-10 Cr | - |
Compare Cash Flow from Financing Activities of peers of SURAKSHA DIAGNOSTIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SURAKSHA DIAGNOSTIC | ₹1,600.3 Cr | -2.7% | -8% | NA | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹124,401.0 Cr | 5% | 1.1% | 33.7% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹107,393.0 Cr | 3% | 5.2% | 14.7% | Stock Analytics | |
FORTIS HEALTHCARE | ₹63,812.8 Cr | 5.4% | 6.9% | 75.8% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹40,697.4 Cr | 3.8% | -3.8% | 57.9% | Stock Analytics | |
GLOBAL HEALTH | ₹35,551.6 Cr | 1.8% | 16.9% | 10% | Stock Analytics |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SURAKSHA DIAGNOSTIC | -2.7% |
-8% |
|
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses